IVD

A Blood Test for Pain?

Indiana University of Medicine researchers said the test can help identify biomarkers in the blood and could actually help in the fight against opioid abuse.

New Assay Gives Greater Insight on HIV

The research behind the development of the test was supported by the National Institute of Allergy and Infectious Diseases, part of NIH.

A New Collaboration Could Be Key in the Early Detection of Lung Cancer

Biodesix and MRM are the latest diagnostic firms to enter into a partnership geared at the early detection of lung cancer.

C2N Launches Trial for Alzheimer’s Detection Test

In addition, the company said it has received a breakthrough device designation for the test, which predicts amyloid PET scan results in patients.

Using Sequencing and AI for Infectious Disease Detection

Day Zero Diagnostics has raised $8.6 million to further develop a sequencing-based rapid diagnostic that identifies, within hours, both the species and the antibiotic resistance profile of a bacterial pathogen.

23andMe Looking at Hereditary Colorectal Cancer Syndrome

The Mountain View, CA-based company received a nod from FDA for the MUTYH-Associated Polyposis Genetic Health Risk report.

New Blood Test Determines Likelihood of Lung Transplant Rejection

The donor-derived cell-free DNA test was developed by the National Institutes of Health/National Heart Blood and Lung Institute.

A Newly Developed Nanosensor Quickly Detects Disease

The test, developed by Researchers at the Institute for Global Food Security at Queen’s University Belfast, can detect proteases, enzyme markers that are responsible for the progression of many diseases.

New Data Boosts Value Proposition of AlloSure

The first donor-derived cell-free DNA test to assess allograft health in kidney transplant patients is also beneficial for repeat transplant recipients, a new study finds.

Antibiotic-Resistance-Screening Diagnostic Wins CE Mark

The new test could help clinicians quickly determine the appropriate treatment for patients.

ArcherDx Seeking Broader Reach for Cancer Diagnostic

The Boulder, CO-based company has been granted a Breakthrough Device Designation for its liquid biopsy and tissue specimen assay.

Noninvasive Test for Colon Cancer Screening Offered as an Alternative to Colonoscopy for Screening

CellMax Life has developed a blood test that it says can identify precancerous adenomas with similar accuracy as colonoscopy, which may facilitate better compliance with screenings and increase detection rates.

New Study Finds Discrepancies in Cervical Cancer Screening Rates

A study from Mayo Clinic researchers shows less than two thirds of women ages 30 to 65 were up-to-date with cervical cancer screenings in 2016, which is below the 81% screening compliance rate self-reported in the 2015 National Health Interview Survey.